These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2476274)

  • 1. Fetal monitoring in the alloimmunized pregnancy.
    Harman CR
    Clin Perinatol; 1989 Sep; 16(3):691-733. PubMed ID: 2476274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful in utero treatment of chronic and massive fetomaternal hemorrhage with fetal hydrops.
    Rubod C; Houfflin V; Belot F; Ardiet E; Dufour P; Subtil D; Deruelle P
    Fetal Diagn Ther; 2006; 21(5):410-3. PubMed ID: 16912488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetomaternal alloimmune thrombocytopenia presenting antenatally as hydrops fetalis.
    Stanworth SJ; Hackett GA; Williamson LM
    Prenat Diagn; 2001 May; 21(5):423-4. PubMed ID: 11360291
    [No Abstract]   [Full Text] [Related]  

  • 4. Ongoing fetomaternal hemorrhage treated by serial fetal intravascular transfusions.
    Rouse D; Weiner C
    Obstet Gynecol; 1990 Nov; 76(5 Pt 2):974-5. PubMed ID: 2216269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
    Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
    Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of serial intravascular transfusions in ascitic/hydropic RhD-alloimmunized fetuses.
    Craparo FJ; Bonati F; Gementi P; Nicolini U
    Ultrasound Obstet Gynecol; 2005 Feb; 25(2):144-8. PubMed ID: 15660441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM; Lindenburg I; van Kamp IL; Meerman RH; Kanhai HH; Oepkes D
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive diagnosis of fetal anemia due to maternal red-cell alloimmunization.
    Ahmed B; Ghaffari Z; Ismail RS; Saleh N
    Saudi Med J; 2005 Feb; 26(2):256-9. PubMed ID: 15770301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonographic evaluation of hydrops fetalis.
    Saltzman DH; Frigoletto FD; Harlow BL; Barss VA; Benacerraf BR
    Obstet Gynecol; 1989 Jul; 74(1):106-11. PubMed ID: 2660040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
    van Kamp IL; Klumper FJ; Bakkum RS; Oepkes D; Meerman RH; Scherjon SA; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient hydrops fetalis associated with intrauterine cytomegalovirus infection: prenatal diagnosis.
    Mazeron MC; Cordovi-Voulgaropoulos L; Pérol Y
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):692-4. PubMed ID: 9205451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine management of fetal parvovirus B19 infection.
    Schild RL; Bald R; Plath H; Eis-Hübinger AM; Enders G; Hansmann M
    Ultrasound Obstet Gynecol; 1999 Mar; 13(3):161-6. PubMed ID: 10204205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal blood sampling in the assessment of acute nonimmune hydrops fetalis.
    Horibe S; Imai A; Kawabata I; Tamaya T
    J Med; 1995; 26(3-4):183-8. PubMed ID: 8558099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrasonic monitoring of intravascular transfusion in severe Rhesus incompatibility. Diagnostic and therapeutic aspects after fetal relaxation].
    Keckstein G; Hütter W; Tschürtz S; Terinde R; Lauritzen C
    Zentralbl Gynakol; 1989; 111(19):1319-24. PubMed ID: 2573984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal hydrops and other variables associated with the fetal hematocrit decrease after the first intrauterine transfusion for red cell alloimmunization.
    Lobato G; Soncini CS
    Fetal Diagn Ther; 2008; 24(4):349-52. PubMed ID: 18849608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of non-immune hydrops: 8 years' experience.
    Anandakumar C; Biswas A; Wong YC; Chia D; Annapoorna V; Arulkumaran S; Ratnam S
    Ultrasound Obstet Gynecol; 1996 Sep; 8(3):196-200. PubMed ID: 8915090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parvovirus B19 infection in pregnancy: a cause of non-immune hydrops fetalis].
    van Gessel PH; Wildschut HI; Cohen-Overbeek TE; Vermeij-Keers C
    Ned Tijdschr Geneeskd; 1999 Jan; 143(1):3-7. PubMed ID: 10086088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icteric serum as an indicator of fetal vascular access during intravascular transfusion for hemolytic disease.
    Moise KJ; Kirshon B; Carpenter RJ; Deter RL
    Am J Perinatol; 1990 Jul; 7(3):279-80. PubMed ID: 2372337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal cerebellar hemorrhage in parvovirus-associated non-immune hydrops fetalis.
    Glenn OA; Bianco K; Barkovich AJ; Callen PW; Parer JT
    J Matern Fetal Neonatal Med; 2007 Oct; 20(10):769-72. PubMed ID: 17763280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Maternal hepatitis B infection as the cause of nonimmunologic hydrops fetalis].
    Schröter B; Chaoui R; Meisel H; Bollmann R
    Z Geburtshilfe Neonatol; 1999; 203(1):36-8. PubMed ID: 10427671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.